In contrast, Glioblastoma multiforme (GBM), Kidney renal clear cell carcinoma (KIRC), Acute Myeloid Leukemia (LAML), Pancreatic adenocarcinoma (PAAD), Testicular Germ Cell Tumors (TGCT), and Thymoma (THYM) showed significantly upregulated expression of TRAF3IP3, with no aberrant expression changes in the rest 25 types of cancer (Figure 1A). This evidence concerns the gene TRAF3IP3 and glioblastoma.